Bone metastases treated with SBRT in oligometastatic cancer: local control and toxicity outcome

被引：0
作者：
Ratosa, Ivica [1 ,2 ]
Culk, Alenka [2 ]
Rankovec, Anja [2 ]
Sedlar, Janja [2 ]
Orazem, Miha [1 ,2 ]
Ciric, Eva [1 ]
Plavc, Gaber [1 ,2 ]
Segedin, Barbara [1 ,2 ]
Ermenc, Ajra Secerov [1 ,2 ]
Hadzic, Jasna But [1 ,2 ]
机构：
[1] Inst Oncol, Div Radiotherapy, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
SBRT; bone metastases; oligometastases;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1590
引用
收藏
页码：S1932 / S1935
页数：4
相关论文
共 50 条
  • [41] Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis
    Robert Foerster
    Christian Eisele
    Thomas Bruckner
    Tilman Bostel
    Ingmar Schlampp
    Robert Wolf
    Juergen Debus
    Harald Rief
    Radiation Oncology, 10
  • [42] Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis
    Foerster, Robert
    Eisele, Christian
    Bruckner, Thomas
    Bostel, Tilman
    Schlampp, Ingmar
    Wolf, Robert
    Debus, Juergen
    Rief, Harald
    RADIATION ONCOLOGY, 2015, 10
  • [43] Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis
    Liao, Xuehong
    Kishi, Kazushi
    Du, Kaixin
    Komaki, Ritsuko
    Mizoe, Junetsu
    Aikawa, Gosuke
    Zheng, Wei
    Pan, Chao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] EORTC QLQ-BM22 Quality of Life Evaluation and Pain Outcome in Patients with Bone Metastases from Breast Cancer Treated with Zoledronic Acid
    Yeh, Dah-Cherng
    Chen, Dar-Ren
    Chao, Tsu-Yi
    Chen, Shin-Cheh
    Wang, Hwei-Chung
    Rau, Kun-Ming
    Feng, Yin-Hsun
    Chang, Yuan-Ching
    Lee, Kuan-Der
    Ou-Yang, Fu
    Kuo, Wen-Hung
    Chang, King-Jen
    Lin, Yung-Chang
    Tseng, Ling-Ming
    Hou, Ming-Feng
    IN VIVO, 2014, 28 (05): : 1001 - 1004
  • [45] Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic acid for detection of bone metastases progression
    Lein, Michael
    Wirth, Manfred
    Miller, Kurt
    Eickenberg, Hans-Udo
    Weissbach, Lothar
    Schmidt, Katja
    Haus, Ulrike
    Stephan, Carsten
    Meissner, Sven
    Loening, Stefan A.
    Jung, Klaus
    EUROPEAN UROLOGY, 2007, 52 (05) : 1381 - 1387
  • [46] Clinical Outcome of Local Treatment in Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Preliminary Analysis of Prospective Data
    Zhu, X.
    Li, S.
    Zheng, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S358 - S358
  • [47] Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: Results from a 2-year multicentre observational study (ZOMAR study)
    Barnadas, Agusti
    Manso, Luis
    de la Piedra, Concepcion
    Meseguer, Cristina
    Crespo, Carmen
    Gomez, Patricia
    Calvo, Lourdes
    Martinez, Purificacion
    Ruiz-Borrego, Manuel
    Perello, Antonia
    Anton, Antonio
    Codes, Manuel
    Margeli, Mireia
    Murias, Adolfo
    Salvador, Javier
    Angel Segui, Miguel
    de Juan, Ana
    Gavila, Joaquin
    Luque, Maria
    Perez, Diego
    Zamora, Pilar
    Arizcuma, Alberto
    Ignacio Chacon, Jose
    Heras, Lucia
    Martin-Fernandez, Marta
    Mahillo-Fernandez, Ignacio
    Tusquets, Ignacio
    BONE, 2014, 68 : 32 - 40
  • [48] Reply to “Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis’”
    Francesco Deodato
    Donato Pezzulla
    Savino Cilla
    Milena Ferro
    Milly Buwenge
    Alessio Giuseppe Morganti
    Gabriella Macchia
    Clinical and Translational Oncology, 2022, 24 : 1217 - 1218
  • [49] Reply to "Letter to the editor regarding 'Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis'"
    Deodato, Francesco
    Pezzulla, Donato
    Cilla, Savino
    Ferro, Milena
    Buwenge, Milly
    Morganti, Alessio Giuseppe
    Macchia, Gabriella
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (06) : 1217 - 1218
  • [50] Bisphosphonates in prevention and control of skeletal-related events in cancer patients with bone metastases
    Drosik, Kazimierz
    Krzakowski, Maciej
    Jarosz, Jerzy
    Kraj, Maria
    Krzemieniecki, Krzysztof
    Pienkowski, Tadeusz
    Utracka-Hutka, Beata
    Jassem, Jacek
    Szczylik, Cezary
    Wojtukiewicz, Marek
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (04): : 152 - 164
12345